This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gao, W. Articles by Cheng, Y.-C. Search for Related Content PubMed PubMed Citation Articles by Gao, W. Articles by Cheng, Y.-C.

Novel Mode of Action of Tylophorine Analogs as Antitumor Compounds

¹ Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut, and
² Department of Chemistry, The University of Tennessee, Knoxville, Tennessee

Tylophorine and its analogs are phenanthroindolizidine alkaloids, several of which have been isolated from the Tylophora genus of plants. Evaluation of (+)-S-tylophorine [DCB-3500 (NSC-717335)] and its analog DCB-3503 (NSC-716802) in the National Cancer Institute tumor screen showed a fairly uniform and potent inhibition of cell growth in all 60 cell lines (GI₅₀ 10^-8 M). To further evaluate the antitumor potential of these compounds, we synthesized four tylophorine analogs, designated DCB-3500, DCB-3501, DCB-3502, and DCB-3503. All four tylophorine analogs exerted potent growth-inhibitory effects against HepG2, a human hepatocellular carcinoma cell line, and KB, a human nasopharyngeal carcinoma cell line. HepG2 cells were more sensitive than KB in terms of loss of clonogenicity. KB variants, which are resistant to etoposide, hydroxyurea, or camptothecin, have similar sensitivities to the tylophorine analogs, as do the parental KB cells. Treatment of nude mice bearing HepG2 tumor xenografts by i.p. injections of DCB-3503 at 6 mg/kg every 8 h on days 0 and 3 resulted in significant tumor growth suppression (P < 0.0001). Unlike conventional antitumor drugs, 3 µM DCB-3503 did not cause DNA breaks or apoptosis in HepG2 cells. Tylophorine analogs induced albumin expression and decreased -fetoprotein expression in HepG2 cells, which suggests that tylophorine analogs could induce HepG2 differentiation. Tylophorine analogs had an inhibitory effect on cyclic AMP response elements, activator protein-1 sites, or nuclear factor-B binding site-mediated transcriptions. In summary, these tylophorine analogs are a unique class of antitumor compounds that have a mode of action different from known antitumor drugs.

This article has been cited by other articles:

				M. A. Rodrigues, D. A. Gomes, M. F. Leite, W. Grant, L. Zhang, W. Lam, Y.-C. Cheng, A. M. Bennett, and M. H. Nathanson Nucleoplasmic Calcium Is Required for Cell Proliferation J. Biol. Chem., June 8, 2007; 282(23): 17061 - 17068. [Abstract] [Full Text] [PDF]

				C.-H. Leung, S. P. Grill, W. Lam, W. Gao, H.-D. Sun, and Y.-C. Cheng Eriocalyxin B Inhibits Nuclear Factor-{kappa}B Activation by Interfering with the Binding of Both p65 and p50 to the Response Element in a Noncompetitive Manner Mol. Pharmacol., December 1, 2006; 70(6): 1946 - 1955. [Abstract] [Full Text] [PDF]

				H.-S. Shiah, W. Gao, D. C. Baker, and Y.-C. Cheng Inhibition of cell growth and nuclear factor-{kappa}B activity in pancreatic cancer cell lines by a tylophorine analogue, DCB-3503. Mol. Cancer Ther., October 1, 2006; 5(10): 2484 - 2493. [Abstract] [Full Text] [PDF]

				C.-W. Yang, W.-L. Chen, P.-L. Wu, H.-Y. Tseng, and S.-J. Lee Anti-Inflammatory Mechanisms of Phenanthroindolizidine Alkaloids Mol. Pharmacol., March 1, 2006; 69(3): 749 - 758. [Abstract] [Full Text] [PDF]

				Y. Wang, Q.-Y. He, R. W.-Y. Sun, C.-M. Che, and J.-F. Chiu Gold(III) Porphyrin 1a Induced Apoptosis by Mitochondrial Death Pathways Related to Reactive Oxygen Species Cancer Res., December 15, 2005; 65(24): 11553 - 11564. [Abstract] [Full Text] [PDF]